Here are the DEF 14A proxy statements from Carlsmed, Inc. (CARL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CARL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CARL filings page.
Carlsmed, Inc. is asking stockholders to vote at its 2026 annual meeting on electing two Class I directors for terms through 2029 and ratifying Ernst & Young LLP as independent registered public accounting firm for 2026.
The meeting is scheduled for June 3, 2026, at 8:00 a.m. Pacific time in San Diego, with an April 8, 2026 record date covering 27,232,278 outstanding common shares. A quorum requires a majority of voting power, and directors are elected by plurality, while auditor ratification needs majority support of shares present and entitled to vote.
The proxy describes Carlsmed’s classified seven-member board, committee structures, and governance policies including a clawback policy and insider trading restrictions. It also details director and executive pay, including 2025 cash bonuses tied to company performance and equity grants such as options and performance-based RSUs for the CEO, and shows that two venture-affiliated groups together beneficially own over half of the common stock.